NNVC vs. ELAB, JAN, FLGC, EDSA, BNTC, VBIV, GRTX, AGE, RDHL, and GHSI
Should you be buying NanoViricides stock or one of its competitors? The main competitors of NanoViricides include Elevai Labs (ELAB), JanOne (JAN), Flora Growth (FLGC), Edesa Biotech (EDSA), Benitec Biopharma (BNTC), VBI Vaccines (VBIV), Galera Therapeutics (GRTX), AgeX Therapeutics (AGE), RedHill Biopharma (RDHL), and Guardion Health Sciences (GHSI). These companies are all part of the "pharmaceutical preparations" industry.
Elevai Labs (NASDAQ:ELAB) and NanoViricides (NYSE:NNVC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends, community ranking, media sentiment and valuation.
22.2% of Elevai Labs shares are held by institutional investors. Comparatively, 10.3% of NanoViricides shares are held by institutional investors. 4.6% of NanoViricides shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
In the previous week, Elevai Labs had 2 more articles in the media than NanoViricides. MarketBeat recorded 2 mentions for Elevai Labs and 0 mentions for NanoViricides. NanoViricides' average media sentiment score of 1.43 beat Elevai Labs' score of 0.00 indicating that Elevai Labs is being referred to more favorably in the media.
Elevai Labs and NanoViricides both received 0 outperform votes by MarketBeat users.
NanoViricides' return on equity of 0.00% beat Elevai Labs' return on equity.
Summary
Elevai Labs beats NanoViricides on 5 of the 6 factors compared between the two stocks.
Get NanoViricides News Delivered to You Automatically
Sign up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NNVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
NanoViricides Competitors List
Related Companies and Tools